Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-12-008189
Filing Date
2012-08-13
Accepted
2012-08-13 15:59:07
Documents
13
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2210644z10-q.htm 10-Q 337607
2 EX-10.1 a2210644zex-10_1.htm EX-10.1 539478
3 EX-10.2 a2210644zex-10_2.htm EX-10.2 804743
4 EX-31.1 a2210644zex-31_1.htm EX-31.1 7765
5 EX-31.2 a2210644zex-31_2.htm EX-31.2 7707
6 EX-32.1 a2210644zex-32_1.htm EX-32.1 4498
7 EX-32.2 a2210644zex-32_2.htm EX-32.2 4424
  Complete submission text file 0001047469-12-008189.txt   5353545

Data Files

Seq Description Document Type Size
8 EX-101.INS vstm-20120630.xml EX-101.INS 519736
9 EX-101.SCH vstm-20120630.xsd EX-101.SCH 33608
10 EX-101.CAL vstm-20120630_cal.xml EX-101.CAL 48268
11 EX-101.DEF vstm-20120630_def.xml EX-101.DEF 199001
12 EX-101.LAB vstm-20120630_lab.xml EX-101.LAB 573569
13 EX-101.PRE vstm-20120630_pre.xml EX-101.PRE 277542
Mailing Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142 617-252-9300
Verastem, Inc. (Filer) CIK: 0001526119 (see all company filings)

EIN.: 273269467 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35403 | Film No.: 121027652
SIC: 2834 Pharmaceutical Preparations